Danxing antifibrillation granule

Danxing antifibrillation granule is a Traditional Chinese Medicine (TCM) herbal formulation developed by the Affiliated Hospital of Shaanxi University of Chinese Medicine for the treatment of Parkinson's disease. It is administered as an oral granule, often in combination with standard antiparkinsonian medications. The prescription is currently being evaluated in clinical trials in China to assess its impact on clinical symptoms and to investigate its underlying biological mechanisms using transcriptomic analysis. As a multi-component botanical product, it likely exerts its effects through multiple pathways involved in neuroprotection and motor symptom management.